Status | Study |
Active, not recruiting |
Study Name: Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors Condition: Hematuria, Nephrolithiasis Ca Date: 2014-08-29 Interventions: Device: Laser confocal microscopy Patients undergoing a reno-ureteroscopy for diagnosis or treatment ind |
Recruiting |
Study Name: Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH) Condition: Microscopic Hematuria Date: 2014-08-08 Interventions: Drug: Premarin vaginal estrogen cream |
Completed |
Study Name: Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder Condition: The Follow-up Duration Was 1-8 Years. The Main Reasons Behind Visiting the Hospital Were Rec Date: 2014-03-14 Interventions: Drug: Second-generation cephalosporin, nitrofurantoin, 1% aminoglycoside sol |
Completed |
Study Name: Diclofenac Suppository to Control Pain During Flexible Cystoscopy Condition: Pain Hematuria Lower Urinary Date: 2013-03-14 Interventions: Drug: Diclofenac Other Name: Non steroidal anti-inflammatory drug |
Terminated |
Study Name: Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer Condition: Hematuria Bladder Cancer Date: 2012-11-28 Interventions: Drug: Valproic Acid 500 mg orally, once daily for up to 30 days |
Completed |
Study Name: Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population Condition: Asymptomatic General Population Microscopic Hematuria Date: 2012-06-06 |
Terminated |
Study Name: Comparison of Microtrauma in Urethra After Usage of Different Catheters Condition: Hematuria Date: 2012-04-24 Interventions: Device: LoFric Three catheteri |
Active, not recruiting |
Study Name: Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer Condition: Hematuria Dysuria Bladder Can Date: 2012-03-23 |
Withdrawn |
Study Name: Velcade for Proliferative Lupus Nephritis Condition: Lupus Nephritis Proteinuria Hematuri Date: 2010-07-23 Interventions: Drug: Velcade Velcade at 1.3 mg/m2, on days 1, 4, 8 and 11 (=1 cycle). The study will involve 3 cycles o |
Completed |
Study Name: Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer Condition: Microscopic or Gross Hematuria Date: 2009-09-10 |